MPC Therapeutics

Plan-les-ouates, Switzerland

MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.

$113K raised

Nov 2023

Debt Financing

Biotechnology Health Care Medical

Top Investors

Innosuisse Plutus Investment Group FONGIT Innovation Fund KICK Ventures Eclosion SA

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MPC Therapeutics

How much funding has MPC Therapeutics raised?

MPC Therapeutics has raised $113K in total funding. The most recent round was Debt Financing. The last funding was announced in November 2023.

Who are MPC Therapeutics's investors?

MPC Therapeutics's investors include Innosuisse, Plutus Investment Group, FONGIT Innovation Fund, KICK Ventures, Eclosion SA.

Where is MPC Therapeutics headquartered?

MPC Therapeutics is headquartered in Plan-les-ouates, Switzerland.

What does MPC Therapeutics do?

MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.

What stage is MPC Therapeutics at?

MPC Therapeutics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 16, 2023.

MLA

"MPC Therapeutics — Funding & Investors." VCBacked, November 16, 2023, https://www.vcbacked.co/company/mpc-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). MPC Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mpc-therapeutics

Wikipedia (cite web)

{{cite web |title=MPC Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mpc-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 16, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K